METHODS	After 16 weeks of therapy , a biopsy was performed for histopathological , immunohistochemical and gene expression ( type I collagen ( COL1A1 ) , type III collagen ( COL3A1 ) , tenascin-C ( TNC ) , tenomodulin ( TNMD ) , and scleraxis ( SCX ) ) analyses .\